These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8638288)

  • 1. Recombinant human interleukin-6: safety issues of a pleiotropic growth factor.
    Kammüller ME
    Toxicology; 1995 Dec; 105(1):91-107. PubMed ID: 8638288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biology of interleukin-6.
    Hirano T
    Chem Immunol; 1992; 51():153-80. PubMed ID: 1567541
    [No Abstract]   [Full Text] [Related]  

  • 3. IL-6 signal transduction and its physiological roles: the signal orchestration model.
    Kamimura D; Ishihara K; Hirano T
    Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evidence for interleukin-6 as an autocrine growth factor in malignancy.
    Akira S; Kishimoto T
    Semin Cancer Biol; 1992 Feb; 3(1):17-26. PubMed ID: 1643291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology induced by interleukin-6.
    Ryffel B; Mihatsch MJ; Woerly G
    Int Rev Exp Pathol; 1993; 34 Pt A():79-89. PubMed ID: 8454418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and clinical aspects of interleukin 6.
    Hirano T; Akira S; Taga T; Kishimoto T
    Immunol Today; 1990 Dec; 11(12):443-9. PubMed ID: 2127356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6: a comprehensive review.
    Lotz M
    Cancer Treat Res; 1995; 80():209-33. PubMed ID: 8821579
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathology induced by interleukin-6.
    Ryffel B; Kammüller M; Robison R; Myers L
    Toxicol Lett; 1992 Dec; 64-65 Spec No():311-9. PubMed ID: 1471186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy.
    Tanaka T; Narazaki M; Ogata A; Kishimoto T
    Semin Immunol; 2014 Feb; 26(1):88-96. PubMed ID: 24594001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6: historical background, genetics and biological significance.
    Wolvekamp MC; Marquet RL
    Immunol Lett; 1990; 24(1):1-9. PubMed ID: 2197219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of IL-6 in Immunity and Diseases.
    Tanaka T; Narazaki M; Masuda K; Kishimoto T
    Adv Exp Med Biol; 2016; 941():79-88. PubMed ID: 27734409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 6 and its receptor in the immune response and hematopoiesis.
    Hirano T; Taga T; Matsuda T; Hibi M; Suematsu S; Tang B; Murakami M; Kishimoto T
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():155-66; discussion 166-7. PubMed ID: 2324554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of interleukin-6 signal blockade on immune system, reproductive and skeletal development in juvenile mice.
    Sakurai T; Takai R; Bürgin H; Shioda A; Sakamoto Y; Amano J; Grimm HP; Richter WF; Higuchi Y; Chiba S; Kawamura A; Suzuki M; Müller L
    Birth Defects Res B Dev Reprod Toxicol; 2013 Apr; 98(2):170-82. PubMed ID: 23529913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biology and medical implications of interleukin-6.
    Tanaka T; Kishimoto T
    Cancer Immunol Res; 2014 Apr; 2(4):288-94. PubMed ID: 24764575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 and its relation to inflammation and disease.
    Hirano T
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S60-5. PubMed ID: 1728989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
    Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
    Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 in autoimmune disorders.
    Yoshizaki K; Kuritani T; Kishimoto T
    Semin Immunol; 1992 Jun; 4(3):155-66. PubMed ID: 1627787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential use of recombinant human interleukin-6 in clinical oncology.
    Veldhuis GJ; Willemse PH; Mulder NH; Limburg PC; De Vries EG
    Leuk Lymphoma; 1996 Feb; 20(5-6):373-9. PubMed ID: 8833392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases.
    Ohsugi Y
    Biol Pharm Bull; 2007 Nov; 30(11):2001-6. PubMed ID: 17978466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis.
    Spohn G; Keller I; Beck M; Grest P; Jennings GT; Bachmann MF
    Eur J Immunol; 2008 Mar; 38(3):877-87. PubMed ID: 18253928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.